Raaj Trivedi, BioClinica's VP Commercial Operations, just received 17,500 options from the company. The strike price of the options received was $1.34, and these expire on February 28, 2026. Trivedi now owns at least 17,500 options on the company.
Some additional info was provided as follows:
25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To re ceive a free e-mail notification whenever BioClinica makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept's Sr VP Comm. Operations just declared owning 2,900 shares of Biocept - Feb. 16, 2017
Biocept’S Ceo Issues Letter To Stockholders - Feb. 9, 2017
Bin Li just provided an update on activist position in Biocept - Jan. 27, 2017
Major owner of Biocept just disposed of 1,681,000 shares - Jan. 26, 2017
On November - Jan. 25, 2017